Arbor Dental Associates Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 34405 W 12 Mile Rd, Ste 187, Farmington Hills, MI 48331 Phone: 248-553-9393 Fax: 248-553-7644 |
Desai Dental Spa, Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 28535 Orchard Lake Rd, Suite # 400, Farmington Hills, MI 48334 Phone: 248-848-1126 |
Thomas C. Mannino Dds, Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 27600 Farmington Rd Ste 101, Farmington Hills, MI 48334 Phone: 248-219-2584 |
Children's Dental Health Foundation Dentist Medicare: Not Enrolled in Medicare Practice Location: 33533 W 12 Mile Rd, Suite 150, Farmington Hills, MI 48331 Phone: 888-833-8441 Fax: 888-330-4331 |
Orchard Dental Group Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 28124 Orchard Lake Rd Ste 100, Farmington Hills, MI 48334 Phone: 248-855-4445 |
Kakos Dental Dentist Medicare: Not Enrolled in Medicare Practice Location: 32905 W 12 Mile Rd, Suite 240, Farmington Hills, MI 48334 Phone: 248-489-5950 Fax: 248-489-9667 |
Mirza M. Baig, D.d.s. & Associates Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 23800 Orchard Lake Rd, Ste. 106, Farmington Hills, MI 48336 Phone: 248-755-5700 Fax: 248-471-7383 |
News Archive
In a clear victory for public health, a federal judge in Kentucky today rejected a motion by tobacco companies to block key provisions of the new law giving the U.S. Food and Drug Administration (FDA) the power to regulate tobacco products. Specifically, today's decision strongly supports the government's authority to prevent the industry from making health claims about its products without FDA approval.
Repros Therapeutics today announced financial results for the first quarter ended March 31, 2010.
Starting Down syndrome infants on treadmill training for just minutes a day can help them walk up to four or five months earlier than with only traditional physical therapy, a new study from the University of Michigan says.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its AmicusĀ® blood cell separator for collecting human platelets stored in InterSolĀ® platelet additive solution (PAS 3). Fenwal's InterSolĀ® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
› Verified 9 days ago